ELOX logo

Eloxx Pharmaceuticals (ELOX) Free Cash Flow

Annual FCF

-$31.91 M
+$3.18 M+9.06%

December 31, 2022


Summary


Performance

ELOX Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherELOXcash flowmetrics:

Quarterly FCF

-$3.45 M
-$1.38 M-66.99%

September 30, 2023


Summary


Performance

ELOX Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherELOXcash flowmetrics:

TTM FCF

-$17.99 M
+$3.54 M+16.46%

September 30, 2023


Summary


Performance

ELOX TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherELOXcash flowmetrics:

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

ELOX Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+9.1%+50.7%+50.3%
3 y3 years+19.1%+34.4%+45.1%
5 y5 years-97.3%+62.3%+54.4%

ELOX Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+9.1%-67.0%+65.3%at high+51.3%
5 y5-year-13.3%+19.1%-67.0%+71.1%at high+57.3%
alltimeall time<-9999.0%+19.1%-4487.8%+71.1%-4099.6%+57.3%

Eloxx Pharmaceuticals Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2023
-
-$3.45 M(+67.0%)
-$17.99 M(-16.5%)
Jun 2023
-
-$2.07 M(-69.7%)
-$21.54 M(-26.3%)
Mar 2023
-
-$6.81 M(+20.4%)
-$29.22 M(-8.4%)
Dec 2022
-$31.91 M(-9.1%)
-$5.66 M(-19.1%)
-$31.91 M(-11.9%)
Sep 2022
-
-$6.99 M(-28.3%)
-$36.20 M(-1.8%)
Jun 2022
-
-$9.75 M(+2.7%)
-$36.86 M(-0.1%)
Mar 2022
-
-$9.50 M(-4.5%)
-$36.91 M(+5.2%)
Dec 2021
-$35.09 M(+24.6%)
-$9.95 M(+30.0%)
-$35.09 M(+17.7%)
Sep 2021
-
-$7.66 M(-21.8%)
-$29.81 M(+8.8%)
Jun 2021
-
-$9.80 M(+27.5%)
-$27.41 M(+14.5%)
Mar 2021
-
-$7.68 M(+64.6%)
-$23.93 M(-15.1%)
Dec 2020
-$28.17 M(-28.6%)
-$4.67 M(-11.2%)
-$28.17 M(-14.0%)
Sep 2020
-
-$5.26 M(-16.8%)
-$32.76 M(-15.7%)
Jun 2020
-
-$6.32 M(-47.0%)
-$38.84 M(-7.8%)
Mar 2020
-
-$11.92 M(+28.8%)
-$42.15 M(+6.9%)
Dec 2019
-$39.43 M(+24.8%)
-$9.26 M(-18.4%)
-$39.43 M(+0.2%)
Sep 2019
-
-$11.35 M(+17.9%)
-$39.34 M(+8.9%)
Jun 2019
-
-$9.62 M(+4.6%)
-$36.12 M(+3.0%)
Mar 2019
-
-$9.20 M(+0.5%)
-$35.05 M(+10.9%)
Dec 2018
-$31.60 M(+95.4%)
-$9.16 M(+12.7%)
-$31.60 M(+40.8%)
Sep 2018
-
-$8.13 M(-5.0%)
-$22.44 M(+50.8%)
Jun 2018
-
-$8.55 M(+48.7%)
-$14.88 M(+117.7%)
Mar 2018
-
-$5.75 M(+900.2%)
-$6.84 M(+254.5%)
Dec 2017
-$16.17 M(+739.0%)
-
-
Sep 2017
-
-$575.30 K(+13.1%)
-$1.93 M(+0.1%)
Jun 2017
-
-$508.80 K(+25.0%)
-$1.93 M(-9.7%)
Jun 2017
-$1.93 M(-47.6%)
-
-
Mar 2017
-
-$407.20 K(-7.0%)
-$2.13 M(-16.9%)
Dec 2016
-
-$437.90 K(-23.7%)
-$2.57 M(-17.7%)
Sep 2016
-
-$573.70 K(-19.7%)
-$3.12 M(-15.2%)
Jun 2016
-$3.68 M(-51.7%)
-$714.80 K(-15.0%)
-$3.68 M(-25.3%)
Mar 2016
-
-$841.00 K(-14.9%)
-$4.92 M(-13.9%)
Dec 2015
-
-$988.30 K(-12.7%)
-$5.72 M(-11.5%)
Sep 2015
-
-$1.13 M(-42.3%)
-$6.46 M(-15.0%)
Jun 2015
-$7.60 M(+38.4%)
-$1.96 M(+19.9%)
-$7.60 M(+7.4%)
Mar 2015
-
-$1.64 M(-5.3%)
-$7.08 M(-1.1%)
Dec 2014
-
-$1.73 M(-23.9%)
-$7.15 M(+2.8%)
Sep 2014
-
-$2.27 M(+58.3%)
-$6.96 M(+26.6%)
Jun 2014
-$5.50 M(+24.0%)
-$1.44 M(-16.2%)
-$5.50 M(+6.9%)
Mar 2014
-
-$1.71 M(+11.9%)
-$5.14 M(-3.4%)
Dec 2013
-
-$1.53 M(+88.4%)
-$5.32 M(+19.3%)
Sep 2013
-
-$813.40 K(-24.7%)
-$4.46 M(+0.7%)
Jun 2013
-$4.43 M(-8.4%)
-$1.08 M(-43.0%)
-$4.43 M(-2.9%)
Mar 2013
-
-$1.90 M(+182.2%)
-$4.57 M(+21.4%)
Dec 2012
-
-$671.90 K(-14.2%)
-$3.76 M(-14.5%)
Sep 2012
-
-$783.50 K(-35.5%)
-$4.40 M(-9.0%)
Jun 2012
-$4.84 M
-$1.22 M(+11.3%)
-$4.84 M(-1.2%)
Mar 2012
-
-$1.09 M(-16.8%)
-$4.89 M(-7.1%)
Dec 2011
-
-$1.31 M(+7.6%)
-$5.27 M(-5.2%)
DateAnnualQuarterlyTTM
Sep 2011
-
-$1.22 M(-4.2%)
-$5.56 M(-8.5%)
Jun 2011
-$6.08 M(+9.5%)
-$1.27 M(-13.2%)
-$6.08 M(-19.7%)
Mar 2011
-
-$1.47 M(-8.5%)
-$7.56 M(+10.5%)
Dec 2010
-
-$1.60 M(-7.6%)
-$6.85 M(+13.2%)
Sep 2010
-
-$1.74 M(-37.1%)
-$6.05 M(+8.9%)
Jun 2010
-$5.55 M(+17.0%)
-$2.76 M(+268.1%)
-$5.55 M(+37.4%)
Mar 2010
-
-$749.70 K(-6.8%)
-$4.04 M(-4.5%)
Dec 2009
-
-$804.00 K(-35.1%)
-$4.23 M(-10.3%)
Sep 2009
-
-$1.24 M(-0.6%)
-$4.72 M(-0.7%)
Jun 2009
-$4.75 M(+49.8%)
-$1.25 M(+32.9%)
-$4.75 M(+3.9%)
Mar 2009
-
-$938.20 K(-27.4%)
-$4.57 M(-2.2%)
Dec 2008
-
-$1.29 M(+1.7%)
-$4.67 M(+10.4%)
Sep 2008
-
-$1.27 M(+18.8%)
-$4.23 M(+33.5%)
Jun 2008
-$3.17 M(+25.3%)
-$1.07 M(+2.8%)
-$3.17 M(+19.3%)
Mar 2008
-
-$1.04 M(+21.9%)
-$2.66 M(+11.5%)
Dec 2007
-
-$853.20 K(+311.6%)
-$2.38 M(+2.5%)
Sep 2007
-
-$207.30 K(-62.7%)
-$2.32 M(-8.1%)
Jun 2007
-$2.53 M(-23.9%)
-$556.20 K(-27.3%)
-$2.53 M(-23.8%)
Mar 2007
-
-$765.30 K(-3.7%)
-$3.32 M(-2.2%)
Dec 2006
-
-$794.80 K(+92.4%)
-$3.39 M(+8.6%)
Sep 2006
-
-$413.20 K(-69.3%)
-$3.13 M(-5.9%)
Jun 2006
-$3.32 M(+25.2%)
-$1.35 M(+60.0%)
-$3.32 M(+22.1%)
Mar 2006
-
-$841.10 K(+59.6%)
-$2.72 M(-9.1%)
Dec 2005
-
-$527.00 K(-13.4%)
-$2.99 M(+8.5%)
Sep 2005
-
-$608.80 K(-18.1%)
-$2.76 M(+4.0%)
Jun 2005
-$2.65 M(+18.3%)
-$743.20 K(-33.2%)
-$2.65 M(-8.0%)
Mar 2005
-
-$1.11 M(+278.9%)
-$2.89 M(+32.9%)
Dec 2004
-
-$293.80 K(-41.6%)
-$2.17 M(-6.2%)
Sep 2004
-
-$503.50 K(-48.4%)
-$2.32 M(+3.2%)
Jun 2004
-$2.24 M(+10.2%)
-$974.90 K(+144.1%)
-$2.24 M(+20.8%)
Mar 2004
-
-$399.40 K(-8.8%)
-$1.86 M(-0.1%)
Dec 2003
-
-$438.00 K(+1.5%)
-$1.86 M(-5.0%)
Sep 2003
-
-$431.40 K(-26.6%)
-$1.96 M(-3.9%)
Jun 2003
-$2.04 M(+52.2%)
-$588.00 K(+46.2%)
-$2.04 M(+13.3%)
Mar 2003
-
-$402.10 K(-24.9%)
-$1.80 M(-8.8%)
Dec 2002
-
-$535.30 K(+4.9%)
-$1.97 M(+30.4%)
Sep 2002
-
-$510.40 K(+46.0%)
-$1.51 M(+13.0%)
Jun 2002
-$1.34 M(-11.4%)
-$349.50 K(-39.3%)
-$1.34 M(+4.3%)
Mar 2002
-
-$576.20 K(+666.2%)
-$1.28 M(+24.0%)
Dec 2001
-
-$75.20 K(-77.7%)
-$1.03 M(-27.1%)
Sep 2001
-
-$336.90 K(+14.5%)
-$1.42 M(-6.1%)
Jun 2001
-$1.51 M(-17.0%)
-$294.20 K(-10.3%)
-$1.51 M(+24.2%)
Mar 2001
-
-$327.90 K(-28.7%)
-$1.22 M(+36.9%)
Dec 2000
-
-$459.80 K(+7.3%)
-$888.20 K(+107.3%)
Sep 2000
-
-$428.40 K
-$428.40 K
Jun 2000
-$1.82 M(+66.6%)
-
-
Jun 1999
-$1.09 M(<-9900.0%)
-
-
Jun 1998
$0.00(0.0%)
-
-
Jun 1997
$0.00
-
-

FAQ

  • What is Eloxx Pharmaceuticals annual free cash flow?
  • What is the all time high annual FCF for Eloxx Pharmaceuticals?
  • What is Eloxx Pharmaceuticals annual FCF year-on-year change?
  • What is Eloxx Pharmaceuticals quarterly free cash flow?
  • What is the all time high quarterly FCF for Eloxx Pharmaceuticals?
  • What is Eloxx Pharmaceuticals quarterly FCF year-on-year change?
  • What is Eloxx Pharmaceuticals TTM free cash flow?
  • What is the all time high TTM FCF for Eloxx Pharmaceuticals?
  • What is Eloxx Pharmaceuticals TTM FCF year-on-year change?

What is Eloxx Pharmaceuticals annual free cash flow?

The current annual FCF of ELOX is -$31.91 M

What is the all time high annual FCF for Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals all-time high annual free cash flow is $0.00

What is Eloxx Pharmaceuticals annual FCF year-on-year change?

Over the past year, ELOX annual free cash flow has changed by +$3.18 M (+9.06%)

What is Eloxx Pharmaceuticals quarterly free cash flow?

The current quarterly FCF of ELOX is -$3.45 M

What is the all time high quarterly FCF for Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals all-time high quarterly free cash flow is -$75.20 K

What is Eloxx Pharmaceuticals quarterly FCF year-on-year change?

Over the past year, ELOX quarterly free cash flow has changed by +$3.54 M (+50.67%)

What is Eloxx Pharmaceuticals TTM free cash flow?

The current TTM FCF of ELOX is -$17.99 M

What is the all time high TTM FCF for Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals all-time high TTM free cash flow is -$428.40 K

What is Eloxx Pharmaceuticals TTM FCF year-on-year change?

Over the past year, ELOX TTM free cash flow has changed by +$18.21 M (+50.30%)